Industry: Chemical & Material
Published Date: 2024-01-03
Pages: 123 Pages
Report ld: 3033112
Request Sample
Customized Report
Dioscin Market Size(US$)

CAGR 2024-2030
6.8%
Market Size,2030
USD 7,494.1
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Dioscin is a spirostanyl glycoside that consists of the trisaccharide alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc attached to position 3 of diosgenin via a glycosidic linkage. Dioscin, one of the most widely distributed steroid saponins in plants, exhibits antitumor, antiviral, antifungal, anti-inflammatory, and immunostimulatory activities and has been found in a number of traditional Chinese herbal medicines.
The global market for Dioscin was estimated to be worth US$ 4850 million in 2023 and is forecast to a readjusted size of US$ 7494.1 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Dioscin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dioscin by region & country, by Type, and by Application.
The Dioscin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dioscin.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dioscin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dioscin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dioscin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Dioscin Product Introduction
1.2 Global Dioscin Market Size Forecast
1.2.1 Global Dioscin Sales Value (2019-2030)
1.2.2 Global Dioscin Sales Volume (2019-2030)
1.2.3 Global Dioscin Sales Price (2019-2030)
1.3 Dioscin Market Trends & Drivers
1.3.1 Dioscin Industry Trends
1.3.2 Dioscin Market Drivers & Opportunity
1.3.3 Dioscin Market Challenges
1.3.4 Dioscin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dioscin Players Revenue Ranking (2023)
2.2 Global Dioscin Revenue by Company (2019-2024)
2.3 Global Dioscin Players Sales Volume Ranking (2023)
2.4 Global Dioscin Sales Volume by Company Players (2019-2024)
2.5 Global Dioscin Average Price by Company (2019-2024)
2.6 Key Manufacturers Dioscin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dioscin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dioscin
2.9 Dioscin Market Competitive Analysis
2.9.1 Dioscin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dioscin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dioscin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity Above 99%
3.1.2 Other
3.2 Global Dioscin Sales Value by Type
3.2.1 Global Dioscin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dioscin Sales Value, by Type (2019-2030)
3.2.3 Global Dioscin Sales Value, by Type (%) (2019-2030)
3.3 Global Dioscin Sales Volume by Type
3.3.1 Global Dioscin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dioscin Sales Volume, by Type (2019-2030)
3.3.3 Global Dioscin Sales Volume, by Type (%) (2019-2030)
3.4 Global Dioscin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Antitumor
4.1.2 Antimicrobial
4.1.3 Anti-inflammation
4.1.4 Antioxidant
4.1.5 Other
4.2 Global Dioscin Sales Value by Application
4.2.1 Global Dioscin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dioscin Sales Value, by Application (2019-2030)
4.2.3 Global Dioscin Sales Value, by Application (%) (2019-2030)
4.3 Global Dioscin Sales Volume by Application
4.3.1 Global Dioscin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dioscin Sales Volume, by Application (2019-2030)
4.3.3 Global Dioscin Sales Volume, by Application (%) (2019-2030)
4.4 Global Dioscin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dioscin Sales Value by Region
5.1.1 Global Dioscin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dioscin Sales Value by Region (2019-2024)
5.1.3 Global Dioscin Sales Value by Region (2025-2030)
5.1.4 Global Dioscin Sales Value by Region (%), (2019-2030)
5.2 Global Dioscin Sales Volume by Region
5.2.1 Global Dioscin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dioscin Sales Volume by Region (2019-2024)
5.2.3 Global Dioscin Sales Volume by Region (2025-2030)
5.2.4 Global Dioscin Sales Volume by Region (%), (2019-2030)
5.3 Global Dioscin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dioscin Sales Value, 2019-2030
5.4.2 North America Dioscin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dioscin Sales Value, 2019-2030
5.5.2 Europe Dioscin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dioscin Sales Value, 2019-2030
5.6.2 Asia Pacific Dioscin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dioscin Sales Value, 2019-2030
5.7.2 South America Dioscin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dioscin Sales Value, 2019-2030
5.8.2 Middle East & Africa Dioscin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dioscin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dioscin Sales Value
6.2.1 Key Countries/Regions Dioscin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dioscin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dioscin Sales Value, 2019-2030
6.3.2 United States Dioscin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dioscin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dioscin Sales Value, 2019-2030
6.4.2 Europe Dioscin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dioscin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dioscin Sales Value, 2019-2030
6.5.2 China Dioscin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dioscin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dioscin Sales Value, 2019-2030
6.6.2 Japan Dioscin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dioscin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dioscin Sales Value, 2019-2030
6.7.2 South Korea Dioscin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dioscin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dioscin Sales Value, 2019-2030
6.8.2 Southeast Asia Dioscin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dioscin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dioscin Sales Value, 2019-2030
6.9.2 India Dioscin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dioscin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 TargetMol Chemicals Inc
7.1.1 TargetMol Chemicals Inc Company Information
7.1.2 TargetMol Chemicals Inc Introduction and Business Overview
7.1.3 TargetMol Chemicals Inc Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 TargetMol Chemicals Inc Dioscin Product Offerings
7.1.5 TargetMol Chemicals Inc Recent Development
7.2 ChemScence
7.2.1 ChemScence Company Information
7.2.2 ChemScence Introduction and Business Overview
7.2.3 ChemScence Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ChemScence Dioscin Product Offerings
7.2.5 ChemScence Recent Development
7.3 ApexBio Technology
7.3.1 ApexBio Technology Company Information
7.3.2 ApexBio Technology Introduction and Business Overview
7.3.3 ApexBio Technology Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 ApexBio Technology Dioscin Product Offerings
7.3.5 ApexBio Technology Recent Development
7.4 BOC Sciences
7.4.1 BOC Sciences Company Information
7.4.2 BOC Sciences Introduction and Business Overview
7.4.3 BOC Sciences Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 BOC Sciences Dioscin Product Offerings
7.4.5 BOC Sciences Recent Development
7.5 AdooQ BioScience
7.5.1 AdooQ BioScience Company Information
7.5.2 AdooQ BioScience Introduction and Business Overview
7.5.3 AdooQ BioScience Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 AdooQ BioScience Dioscin Product Offerings
7.5.5 AdooQ BioScience Recent Development
7.6 BLDpharm
7.6.1 BLDpharm Company Information
7.6.2 BLDpharm Introduction and Business Overview
7.6.3 BLDpharm Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BLDpharm Dioscin Product Offerings
7.6.5 BLDpharm Recent Development
7.7 Pharmaffiliates
7.7.1 Pharmaffiliates Company Information
7.7.2 Pharmaffiliates Introduction and Business Overview
7.7.3 Pharmaffiliates Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pharmaffiliates Dioscin Product Offerings
7.7.5 Pharmaffiliates Recent Development
7.8 EXTRASYNTHESE
7.8.1 EXTRASYNTHESE Company Information
7.8.2 EXTRASYNTHESE Introduction and Business Overview
7.8.3 EXTRASYNTHESE Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 EXTRASYNTHESE Dioscin Product Offerings
7.8.5 EXTRASYNTHESE Recent Development
7.9 Cayman Chemical
7.9.1 Cayman Chemical Company Information
7.9.2 Cayman Chemical Introduction and Business Overview
7.9.3 Cayman Chemical Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Cayman Chemical Dioscin Product Offerings
7.9.5 Cayman Chemical Recent Development
7.10 Merck
7.10.1 Merck Company Information
7.10.2 Merck Introduction and Business Overview
7.10.3 Merck Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Merck Dioscin Product Offerings
7.10.5 Merck Recent Development
7.11 Sabinsa Corporation
7.11.1 Sabinsa Corporation Company Information
7.11.2 Sabinsa Corporation Introduction and Business Overview
7.11.3 Sabinsa Corporation Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Sabinsa Corporation Dioscin Product Offerings
7.11.5 Sabinsa Corporation Recent Development
7.12 Himachal Pharmaceuticals
7.12.1 Himachal Pharmaceuticals Company Information
7.12.2 Himachal Pharmaceuticals Introduction and Business Overview
7.12.3 Himachal Pharmaceuticals Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Himachal Pharmaceuticals Dioscin Product Offerings
7.12.5 Himachal Pharmaceuticals Recent Development
7.13 Namiex Chemicals
7.13.1 Namiex Chemicals Company Information
7.13.2 Namiex Chemicals Introduction and Business Overview
7.13.3 Namiex Chemicals Dioscin Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Namiex Chemicals Dioscin Product Offerings
7.13.5 Namiex Chemicals Recent Development
8 Industry Chain Analysis
8.1 Dioscin Industrial Chain
8.2 Dioscin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dioscin Sales Model
8.5.2 Sales Channel
8.5.3 Dioscin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Dioscin was estimated to be worth US$ 5687 million in 2025 and is projected to reach US$ 8956 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 115
USD 3950.00
(Single User License)
The global Dioscin market was valued at US$ 5687 million in 2025 and is anticipated to reach US$ 8956 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 138
USD 2900.00
(Single User License)
The global Dioscin market is projected to grow from US$ 5359 million in 2024 to US$ 8439 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 167
USD 4900.00
(Single User License)
The global market for Dioscin was valued at US$ 5359 million in the year 2024 and is projected to reach a revised size of US$ 8439 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-03-15
Pages: 103
USD 2900.00
(Single User License)
The global Dioscin market size was US$ 5359 million in 2024 and is forecast to a readjusted size of US$ 8439 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 92
USD 4250.00
(Single User License)
The global market for Dioscin was estimated to be worth US$ 5359 million in 2024 and is forecast to a readjusted size of US$ 8439 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 114
USD 3950.00
(Single User License)
Dioscin is a spirostanyl glycoside that consists of the trisaccharide alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc attached to position 3 of diosgenin via a glycosidic linkage. Dioscin, one of the most widely distributed steroid saponins in plants, exhibits antitumor, antiviral, antifungal, anti-inflammatory, and immunostimulatory activities and has been found in a number of traditional Chinese herbal medicines.
Published Date: 2024-04-13
Pages: 111
USD 4900.00
(Single User License)
Dioscin is a spirostanyl glycoside that consists of the trisaccharide alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc attached to position 3 of diosgenin via a glycosidic linkage. Dioscin, one of the most widely distributed steroid saponins in plants, exhibits antitumor, antiviral, antifungal, anti-inflammatory, and immunostimulatory activities and has been found in a number of traditional Chinese herbal medicines.
Published Date: 2024-02-14
Pages: 99
USD 2900.00
(Single User License)
The global market for Dioscin was estimated to be worth US$ 5687 million in 2025 and is projected to reach US$ 8956 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-02-02
Pages: 115
The global Dioscin market was valued at US$ 5687 million in 2025 and is anticipated to reach US$ 8956 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-02-02
Pages: 138
The global Dioscin market is projected to grow from US$ 5359 million in 2024 to US$ 8439 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 167
The global market for Dioscin was valued at US$ 5359 million in the year 2024 and is projected to reach a revised size of US$ 8439 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-03-15
Pages: 103
The global Dioscin market size was US$ 5359 million in 2024 and is forecast to a readjusted size of US$ 8439 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 92
The global market for Dioscin was estimated to be worth US$ 5359 million in 2024 and is forecast to a readjusted size of US$ 8439 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 114
Dioscin is a spirostanyl glycoside that consists of the trisaccharide alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc attached to position 3 of diosgenin via a glycosidic linkage. Dioscin, one of the most widely distributed steroid saponins in plants, exhibits antitumor, antiviral, antifungal, anti-inflammatory, and immunostimulatory activities and has been found in a number of traditional Chinese herbal medicines.
Published: 2024-04-13
Pages: 111
Dioscin is a spirostanyl glycoside that consists of the trisaccharide alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc attached to position 3 of diosgenin via a glycosidic linkage. Dioscin, one of the most widely distributed steroid saponins in plants, exhibits antitumor, antiviral, antifungal, anti-inflammatory, and immunostimulatory activities and has been found in a number of traditional Chinese herbal medicines.
Published: 2024-02-14
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now